Facility #2

London, Middlesex TW7 6FY

0 studies enrolling now · 1 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease — Stopped early